Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Gli-M Tablet

Prescription Icon
Prescription Required

Marketer

Biochem Pharmaceutical Industries

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Gli-M Tablet

Diabetic patients may find relief with Gly-Mend, a dual-action anti-diabetic medication. This adult-specific formulation manages type 2 diabetes mellitus by regulating blood glucose. Always take Gly-Mend with meals, consistently at the same time daily for optimal results. Dosage is determined by your physician and may adjust based on your blood sugar response. Continuous use is crucial; discontinuation without medical advice risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Gly-Mend complements a comprehensive diabetes management plan, including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are vital to manage hypoglycemia. Alcohol consumption should be minimized due to its potential to exacerbate low blood sugar. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. Gly-Mend is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before starting Gly-Mend. Pregnant or breastfeeding women require medical consultation prior to use. Regular blood glucose monitoring, along with blood tests to track blood cell counts and liver function, are recommended under your doctor's guidance.

Uses of Gli-M Tablet

Adult-onset diabetes

Major Benefits of Gli-M Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Gli-M Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.

Common Side effects of Gli-M Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Gli-M Tablet:

Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Gli-M Tablet with a meal.

How Gli-M Tablet works:

Gli-M tablets contain a dual-action formulation of gliclazide and metformin, both antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Gli-M Tablet with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Gli-M Tablet is contraindicated during pregnancy due to established risk to the fetus. In exceptional life-threatening circumstances, a physician may prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Gli-M Tablet while breastfeeding is likely inadvisable. Scant evidence from human studies indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by abnormally low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Gli-M tablets cautiously, potentially requiring dose modification. Severe kidney disease contraindicates Gli-M tablet use. Consult your physician. Regular kidney function monitoring is recommended during Gli-M tablet treatment.

LiverLiverCAUTION

Patients with liver impairment should use Gli-M Tablet cautiously, potentially requiring dosage modification. Consult a physician before use. For those with mild to moderate liver disease, initiate treatment with a low Gli-M Tablet dose; the medication is unsuitable for patients with severe liver dysfunction.

What if you forget to take Gli-M Tablet :

Should you forget a Gli-M Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Gli-M Tablet

LabelValue
Potential for Dependence None.
Medication Classification Medication for diabetes

FAQs on Gli-M Tablet

Gli-M tablets contain gliclazide and metformin, two medications combined to manage type 2 diabetes mellitus in adults. This treatment improves blood sugar control when coupled with a healthy diet and regular physical activity. Gliclazide functions by stimulating insulin secretion from the pancreas, while metformin reduces hepatic glucose production and enhances insulin responsiveness. This dual-agent therapy is unsuitable for type 1 diabetes.
Gli-M Tablet administration is linked to predictable adverse reactions. These may manifest as hypoglycemia, altered taste perception, nausea, abdominal discomfort, diarrhea, cephalalgia, and upper respiratory infections. Less frequent, yet potentially severe, consequences include lactic acidosis. Prolonged therapy may additionally result in vitamin B12 deficiency.
Indeed, Gli-M Tablet administration may result in hypoglycemia, characterized by low blood glucose. Manifestations of this condition can encompass nausea, headache, irritability, hunger pangs, diaphoresis, vertigo, tachycardia, and feelings of anxiety or tremor. The likelihood increases with skipped or delayed meals, alcohol consumption, excessive physical exertion, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying readily available glucose sources, such as glucose tablets, honey, or fruit juice, is strongly recommended.
Gli-M Tablet use carries a risk of lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this is a rare complication. To minimize risk, it's contraindicated in individuals with kidney impairment, the elderly, and heavy alcohol consumers. Lactic acidosis symptoms can manifest as muscle aches or weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, emesis, abdominal pain, or bradycardia. Should these symptoms arise, discontinue Gli-M Tablet and seek immediate medical attention.
Prolonged Gli-M Tablet use can indeed lead to vitamin B12 deficiency. This is because the medication impedes the stomach's absorption of vitamin B12. Untreated deficiency may result in anemia, neurological complications such as tingling, numbness in the extremities, weakness, urinary dysfunction, cognitive changes, and gait instability. To mitigate these risks, supplemental vitamin B12 intake, at least annually, has been proposed by some investigators.
Gli-M Tablet is contraindicated in individuals with hypersensitivity to any ingredient or inactive component. Its use is also prohibited in patients exhibiting moderate to severe renal impairment or pre-existing metabolic acidosis, encompassing diabetic ketoacidosis.
Consuming alcohol concurrently with Gli-M Tablet is unsafe. This combination may exacerbate hypoglycemia and raise the risk of lactic acidosis.
Gli-M Tablets contain gliclazide and metformin, working synergistically to manage type 2 diabetes mellitus in adults. This dual-action therapy enhances glycemic control when combined with a healthy diet and regular physical activity. Gliclazide stimulates pancreatic insulin secretion, while metformin reduces hepatic glucose production and improves insulin responsiveness. This formulation is unsuitable for individuals with type 1 diabetes.
Gli-M Tablet administration is linked to several common adverse reactions. These may manifest as hypoglycemia (low blood glucose), taste disturbances, nausea, abdominal discomfort, diarrhea, cephalalgia, and upper respiratory infections. Serious, though infrequent, side effects such as lactic acidosis are also possible. Prolonged therapy may result in vitamin B12 depletion.
Indeed, Gli-M Tablet use may result in hypoglycemia, characterized by low blood sugar. Manifestations of low blood sugar can include nausea, headache, irritability, hunger pangs, sweating, dizziness, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is advisable.
Gli-M Tablet use can result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this is an uncommon complication of metformin. It's contraindicated in individuals with pre-existing kidney impairment, the elderly, and those who consume significant alcohol. Symptoms may involve muscle aches or weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, emesis, abdominal discomfort, or bradycardia. Should these symptoms arise, discontinue Gli-M Tablet and seek immediate medical attention.
Prolonged Gli-M Tablet use can indeed lead to vitamin B12 deficiency. This is because the medication hinders the stomach's absorption of vitamin B12. Left unaddressed, this deficiency can result in anemia, neurological issues, including tingling and numbness in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and impaired balance. To mitigate these risks, supplemental vitamin B12 intake, at a minimum of once annually, is recommended by some studies.
Patients with hypersensitivity to any ingredient or inactive component within Gli-M Tablet should not use this medication. Its use is also contraindicated in individuals with moderate to severe renal impairment or pre-existing metabolic acidosis, such as diabetic ketoacidosis.
Combining Gli-M Tablet and alcohol is unsafe. This combination can reduce blood sugar to dangerously low levels, increasing the risk of lactic acidosis.
Gli-M Tablet
96
MRP 116
17% off